전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved59 programs
CGTLimited DatastaleShenzhen University General Hos…Preclinical

Claudin18.2 CAR-T cells (Claudin18.2 CAR-T cells)

Advanced Pancreatic Carcinoma; Advanced Gastric Carcinoma · Advanced Pancreatic Carcinoma

#AdvancedPancreaticCarcinoma#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
ADCLimited DatastaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin combined with fruquintinib and Tislelizumab)

HER2-positive Gastric Cancer; Immunotherapy · HER2

#HER2#ADC#Phase2#antibody-drug-conjugate#HER2-positiveGastricCancer+2
Trials 1Status Active
ADCLimited DatastaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab vedotin + Sintilimab + Multimodality radiotherapy)

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#ADC#Phase2#antibody-drug-conjugate#HER2-positiveAdvancedGastricCanc+1
Trials 1Status Recruiting
CGTLimited DatastaleNanjing Legend Biotech Co.Phase 1

LCAR-C182A cells (LCAR-C182A cells)

Gastric Cancer; Pancreatic Ductal Adenocarcinoma · Gastric Cancer

#GastricCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
AntibodyLimited DatastaleM.D. Anderson Cancer CenterPhase 1

LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide (LVGN3616 + LVGN6051 + Bevacizumab + Cyclophosphamide)

Metastatic Esophageal; Gastric Cancer · Metastatic Esophageal

#MetastaticEsophageal#Antibody#Phase1#monoclonal-antibody#GastricCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleM.D. Anderson Cancer CenterPhase 1

LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide (LVGN3616 + LVGN6051 + LVGN7409 + Bevacizumab + Cyclophosphamide)

Metastatic Esophageal; Gastric Cancer · Metastatic Esophageal

#MetastaticEsophageal#Antibody#Phase1#monoclonal-antibody#GastricCancer+1
Trials 1Status Recruiting
CGTLimited Datastalejiuwei cuiPhase 1

PD-1-M1-NK Cells (PD-1-M1-NK Cells)

Advanced Gastric or Colorectal Cancer · PD-1

#PD-1#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
AntibodyLimited DatastaleShanghai JMT-Bio Inc.Phase 2

Pembolizumab (Pembolizumab)

HER2-positive Gastric Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#HER2-positiveGastricCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleXijing HospitalPreclinical

Penpulimab combination with anlotinib and chemotherapy (Penpulimab combination with anlotinib and chemotherapy)

Gastric Cancer · Gastric Cancer

#GastricCancer#Antibody#Preclinical#monoclonal-antibody#Xijing
Trials 1Status Active
AntibodyLimited DatastaleThe First Affiliated Hospital w…Phase 2

Iparomlimab/Tuvonralimab (QL1706, QL1706 (Iparomlimab/Tuvonralimab))

Gastric Cancer Stage III · Gastric Cancer Stage III

#GastricCancerStageIII#Antibody#Phase2#monoclonal-antibody#The
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

QLS5132; Bevacizumab (QLS5132; Bevacizumab)

Gastric Cancer (GC); Non-small Cell Lung Cancer (NSCLC) · Gastric Cancer (GC)

#GastricCancerGC#Antibody#Phase2#monoclonal-antibody#Non-smallCellLungCancerNSCLC+1
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

QLS5132; Platinum; Bevacizumab (QLS5132; Platinum; Bevacizumab)

Gastric Cancer (GC); Non-small Cell Lung Cancer (NSCLC) · Gastric Cancer (GC)

#GastricCancerGC#Antibody#Phase2#monoclonal-antibody#Non-smallCellLungCancerNSCLC+1
Trials 1Status Recruiting
CGTLimited DatastaleCNBG-Virogin Biotech (Shanghai)…Phase 2

Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell, Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection, Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)))

Metastatic Gastric Cancer · MET

#MET#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
ADCLimited DatastaleRemeGen Co., Ltd.Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, Short range radiotherapy with sequential Disitamab Vedotin combined with S-1 and xindilizumab)

Gastric Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#antibody-drug-conjugate#RemeGen
Trials 1Status Recruiting
AntibodyLimited DatastaleTriumvira Immunologics, Inc.Phase 2

pembrolizumab (Keytruda, TAC01-HER2 plus pembrolizumab)

HER2 Positive Gastric Cancer; Metastatic HER2 Positive Gastroesophageal Junction Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#HER2PositiveGastricCancer+2
Trials 1Status Discontinued
AntibodyLimited DatastaleBeiGenePhase 1

trastuzumab (Herceptin, Tislelizumab，atezolizumab or Trastuzumab)

Gastric Cancer · Gastric Cancer

#GastricCancer#Antibody#Phase1#monoclonal-antibody#BeiGene
Trials 1Status Active
ADCLimited DatastaleDaiichi SankyoPhase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Trastuzumab deruxtecan + FLO)

Esophagogastric Adenocarcinoma · Esophagogastric Adenocarcinoma

#EsophagogastricAdenocarcinoma#ADC#Phase2#antibody-drug-conjugate#Daiichi
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

Tucidinostat (Tucidinostat, Tucidinostat (chidamide), PD-1 inhibitor (Toripalimab), Bevacizumab, chidamide)

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma · PD-1

#PD-1#Antibody#Phase2#monoclonal-antibody#EsophagealSquamousCellCancer+3
Trials 1Status Active
AntibodyLimited DatastaleFujian Cancer HospitalPreclinical

nivolumab (Opdivo, XBI-302 + Nivolumab)

Gastric Adenocarcinoma; Esophagogastric Junction Adenocarcinoma · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Preclinical#monoclonal-antibody#EsophagogastricJunctionAdenocarc+1
Trials 1Status Discontinued

3 / 3 pages

← PreviousNext →